LFCR vs AAPL: Which Stock is Better?

Side-by-side comparison of Lifecore Biomedical Inc and Apple Inc in 2026

Comparison Updated:

LFCR

Lifecore Biomedical Inc

$5.38

AAPL

Apple Inc

$269.84

Key Metrics Comparison

MetricLFCRAAPLWinner
Market Cap$194.88MN/ALFCR
P/E RatioN/A33.32AAPL
EPS (TTM)$N/A$8.11AAPL
Revenue Growth-0.0%0.2%AAPL
Gross Margin31.4%47.3%AAPL

Analyze LFCR

Full quant analysis

Analyze AAPL

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is LFCR or AAPL a better investment?

Comparing LFCR and AAPL: Lifecore Biomedical Inc has a market cap of $194.88M while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between LFCR and AAPL?

LFCR (Lifecore Biomedical Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: LFCR or AAPL?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: LFCR or AAPL?

AAPL has higher revenue growth at 0.2% vs -0.0% for LFCR.

Which company is more profitable: LFCR or AAPL?

Apple Inc (AAPL) has higher gross margins at 47.3% compared to 31.4% for LFCR.

Which is the larger company: LFCR or AAPL?

Lifecore Biomedical Inc (LFCR) is larger with a market cap of $194.88M compared to N/A for AAPL.

Should I buy LFCR or AAPL in 2026?

Both LFCR and AAPL have investment merit. LFCR trades at $5.38 while AAPL trades at $269.84. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between LFCR and AAPL stock?

Key differences: Market Cap ($194.88M vs N/A), P/E Ratio (N/A vs 33.3x), Revenue Growth (-0.0% vs 0.2%), Gross Margin (31.4% vs 47.3%).

Popular Stock Comparisons